SentiAR

company

About

Digital health company with holographic AR platform for intraprocedural clinical use.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.20M
Industries
3D Technology,Augmented Reality,Biotechnology,Health Care,Medical Device,Software
Founded date
Jun 5, 2017
Number Of Employee
11 - 50
Operating Status
Active

SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal to provide the clinician and patient a faster, safer delivery of care.

SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.

The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.20M
SentiAR has raised a total of $2.20M in funding over 2 rounds. Their latest funding was raised on Feb 13, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 13, 2018 Grant $2.20M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
SentiAR is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant